22- 23 October, 2020

3rd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress

Boston, MA
30+
Speaker
10+
Networking Hours
150+
Attendees

MarketsandMarkets is proud to announce the 3rd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress to be held on October 22-23, 2020 in Boston, USA.

While the 2nd annual Congress had discussions on accelerating the adoption of Real-world Evidence within the industry while understanding the capabilities of newer technologies for evidence generation, the 3rd Annual will focus on how the insights derived from real world data, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators, doctors, and payers.

Click here to see the post-show report of our 2nd Edition of the congress.

users

Learn how the adoption of real-world evidence can be accelerated across the pharmaceutical industry

users

Explore capabilities of using Artificial Intelligence & Machine Learning in taming scientific research

users

Understand the impact of innovative real-world evidence partnerships for better data

Our aim for the 3rd Annual Real-World Data and Life Science Analytics Congress is to unite all stakeholders to see how to use conventional informational indexes and layer that in with innovative analytical techniques and new working models.

 

WHAT TO EXPECT
Why Attend?
  • To explore capabilities of using Artificial Intelligence & Machine Learning in taming scientific research
  • To understand the impact of innovative real-world evidence partnerships for better data
Who Should Attend?

From Pharmaceutical and Biopharmaceutical companies

  • Chief executives
  • VP’s
  • Directors
  • Global heads
  • Heads
  • Leaders
  • Senior Managers
  • Researcher
  • Analysts
  • Investigators
  • Scientists
  • Bio-Statisticians
  • Epidemiologists
Departments
  • Real-World Evidence
  • Health Economics & Outcomes Research
  • Market Access
  • Value Access
  • Clinical Outcomes
  • Clinical Development
  • Center for Observational and Real-World Evidence  
CONFERENCE SPEAKERS
Advisors
Nneka Onwudiwe

Nneka Onwudiwe

Founder and Chief Executive Officer
Pharmaceutical Economics Consultants of America

Nneka Onwudiwe

Founder and Chief Executive Officer
Pharmaceutical Economics Consultants of America
Alexander Cole

Alexander Cole

Executive Director, Global Head Epidemiology
Alexion Pharmaceuticals

Alexander Cole

Executive Director, Global Head Epidemiology
Alexion Pharmaceuticals
Speakers
Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets
Nneka Onwudiwe

Nneka Onwudiwe

Founder and Chief Executive Officer
Pharmaceutical Economics Consultants of America

Nneka Onwudiwe

Founder and Chief Executive Officer
Pharmaceutical Economics Consultants of America
Susan Fish

Susan Fish

Associate Director, Strategic Evidence Integration and Collaborations US Medical Affairs Hematology,
Bristol-Myers Squibb

Susan Fish

Associate Director, Strategic Evidence Integration and Collaborations US Medical Affairs Hematology,
Bristol-Myers Squibb
Alexander Cole

Alexander Cole

Executive Director, Global Head Epidemiology
Alexion Pharmaceuticals

Alexander Cole

Executive Director, Global Head Epidemiology
Alexion Pharmaceuticals
SPONSORS
Sponsors & Exhibitors
example-image

Syneos Health

example-image

Adelphi Real World

PARTNERS
Media Partners
example-image

MedNous

LOCATION
Boston, MA
About the Hotel

PAST EVENT GALLERY